Presence of JAK2V617F mutation correlated with a reduced level of thrombocytosis in ET and increased absolute number of circulating CD34+ cells, leukocytosis, and erythrocytosis in patients with PV. The gene discussed is CD34; the disease is Thrombocytosis.